Dingdang Health (09886) Reports Share Repurchases Without Changing Overall Issued Shares

Bulletin Express2025-12-01

Dingdang Health Technology Group Ltd. (09886) submitted a Next Day Disclosure Return dated 1 December 2025, confirming that the total number of issued ordinary shares remained at 1,319,472,897 as of 1 December 2025. The company reported multiple share buybacks from 25 November to 1 December 2025, totaling 972,000 shares repurchased but not yet cancelled as of the closing balance date, at prices generally ranging from HKD 1.051 to HKD 1.0888.

On 1 December 2025, 72,000 shares were repurchased on the market at prices between HKD 1.07 and HKD 1.09, with a total consideration of approximately HKD 77,860.8. These transactions were conducted under the share repurchase mandate approved on 28 May 2025, which authorized up to 131,947,289 shares to be repurchased. The share buybacks so far represent about 0.073666% of the issuer’s share capital as of the mandate date. A moratorium on new share issuances is in effect until 1 January 2026 under the related rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189876178?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-01 19:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189876178","market":"hk","top_or_hot":-1,"title":"Dingdang Health (09886) Reports Share Repurchases Without Changing Overall Issued Shares","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. (09886) submitted a Next Day Disclosure Return dated 1 December 2025, confirming that the total number of issued ordinary shares remained at 1,319,472,897 as of 1 December 2025. The company reported multiple share buybacks from 25 November to 1 December 2025, totaling 972,000 shares repurchased but not yet cancelled as of the closing balance date, at prices generally ranging from HKD 1.051 to HKD 1.0888.</p>\n<p>On 1 December 2025, 72,000 shares were repurchased on the market at prices between HKD 1.07 and HKD 1.09, with a total consideration of approximately HKD 77,860.8. These transactions were conducted under the share repurchase mandate approved on 28 May 2025, which authorized up to 131,947,289 shares to be repurchased. The share buybacks so far represent about 0.073666% of the issuer’s share capital as of the mandate date. A moratorium on new share issuances is in effect until 1 January 2026 under the related rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health (09886) Reports Share Repurchases Without Changing Overall Issued Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health (09886) Reports Share Repurchases Without Changing Overall Issued Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-01 19:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. (09886) submitted a Next Day Disclosure Return dated 1 December 2025, confirming that the total number of issued ordinary shares remained at 1,319,472,897 as of 1 December 2025. The company reported multiple share buybacks from 25 November to 1 December 2025, totaling 972,000 shares repurchased but not yet cancelled as of the closing balance date, at prices generally ranging from HKD 1.051 to HKD 1.0888.</p>\n<p>On 1 December 2025, 72,000 shares were repurchased on the market at prices between HKD 1.07 and HKD 1.09, with a total consideration of approximately HKD 77,860.8. These transactions were conducted under the share repurchase mandate approved on 28 May 2025, which authorized up to 131,947,289 shares to be repurchased. The share buybacks so far represent about 0.073666% of the issuer’s share capital as of the mandate date. A moratorium on new share issuances is in effect until 1 January 2026 under the related rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1189876178","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189876178","pubTimestamp":1764588342,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. (09886) submitted a Next Day Disclosure Return dated 1 December 2025, confirming that the total number of issued ordinary shares remained at 1,319,472,897 as of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康(09886)报告在不改变整体已发行股份的情况下购回股份","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. (09886) submitted a Next Day Disclosure Return dated 1 December 2025, confirming that the total number of issued ordinary shares remained at 1,319,472,897 as of 1 December 2025. The company reported multiple share buybacks from 25 November to 1 December 2025, totaling 972,000 shares repurchased but not yet cancelled as of the closing balance date, at prices generally ranging from HKD 1.051 to HKD 1.0888.\nOn 1 December 2025, 72,000 shares were repurchased on the market at prices between HKD 1.07 and HKD 1.09, with a total consideration of approximately HKD 77,860.8. These transactions were conducted under the share repurchase mandate approved on 28 May 2025, which authorized up to 131,947,289 shares to be repurchased. The share buybacks so far represent about 0.073666% of the issuer’s share capital as of the mandate date. A moratorium on new share issuances is in effect until 1 January 2026 under the related rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189876178","isCrawlerRequest":true}